FTO and cardiac hypertrophy: Collectively, these findings identify FTO-dependent m6A methylation as a critical epigenetic mechanism underlying GDM-induced cardiac dysfunction and suggest that targeting FTO may offer a therapeutic approach to prevent cardiac hypertrophy in offspring.